(*) USA Approval: 2010. 09.14. (Alo
(*) USA Approval: 2022. 07.08. (+
>Oxidase Inj.
Company
Generic Name: PEGloticase
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 20
Patent>UpDate: 2022. 07.12
RTM
RTM Web-Site